Contact us
Let’s discuss your asset.
Tell us about your company, your asset and your objectives for Korea.
We will come back to you with an initial assessment.
Partnering inquiries
Every message is read by our leadership team, and every asset is reviewed with care.
contact [at] vegatopharma.comWe reply within five working days.
Confidential documents are shared under NDA once we agree to proceed.
We look forward to hearing about your asset.
Helpful to include in your first email
- Company name, website and country
- Your name and title
- Product category and a short description
- Where it is approved and sold today
- Available clinical data
- Whether anyone holds Korean rights
Frequently asked questions
What should I send first?
A short, non-confidential summary: the product, where it is approved and sold, available clinical data and whether anyone holds Korean rights. Confidential documents follow under NDA.
Do you charge for consulting or to get started?
No. We do not charge upfront or consulting fees. Commercial terms are discussed and agreed in writing before a deal goes ahead.
Will you introduce us and then step away?
No. We stay involved through negotiation, contract and launch, and our agreements protect both sides when we make an introduction.
We already have a partner in Korea. Can we still talk?
Yes. Please tell us the scope of your existing rights and any contractual limits first, so we can see what is possible.
Do you guarantee a deal or approval?
No. We bring the right partners to the table and support every step, but signing, approval and launch depend on the product and both parties.